IPO Daily NewsTM

A quick read, the IPO Daily NewsTM is three to five concise paragraphs a day. It includes summaries of all patent and trademark opinions of the U.S. Court of Appeals for the Federal Circuit, the next day after opinions are issued and wire service stories of other selected IP cases.

Written Description Decision Vacated and Remanded for Predictability and Criticality to be Addresses

** WRITTEN DESCRIPTION DECISION VACATED AND REMANDED FOR PREDICTABILITY AND CRITICALITY TO BE ADDRESSED In re: Global IP Holdings LLC, 18-1426 -- On July 5 in an opinion by Judge STOL[...]

IPO Publishes Top 300 Patent Owners List

IPO PUBLISHES TOP 300 PATENT OWNERS LIST Today IPO published its 2018 Top 300 Patent Owners List. The list reports the 300 companies that received the most U.S. utility patents in calendar year 201[...]

Substantial Evidence Supported USPTO Obviousness Decision Where Prior Conception Not Established by Patent Owner

* SUBSTANTIAL EVIDENCE SUPPORTED USPTO OBVIOUSNESS DECISION WHERE PRIOR CONCEPTION NOT ESTABLISHED BY PATENT OWNER Kolcraft Enterprises, Inc. v. Grace Children’s Prod., Inc., 18-1259 [...]

IPO Files Amicus Brief in EPO’s Enlarged Board of Appeal

IPO FILES AMICUS BRIEF IN EPO’S ENLARGED BOARD OF APPEAL On June 28 IPO filed an amicus brief with the European Patent Office concerning the case G2/19 before the Enlarged Board of Appeal, which co[...]

IPO Comments on Patent Working Requirement in India

IPO COMMENTS ON PATENT WORKING REQUIREMENT IN INDIA On Friday IPO President HENRY HADAD submitted IPO’s comments to the Government of India on India’s draft “Patents (Amendment) Rules, 2019” that a[...]

Senate Judiciary Approves Drug Pricing Bills

SENATE JUDICIARY APPROVES DRUG PRICING BILLS Yesterday the Senate Judiciary Committee approved four bills intended to stem drug prices, several of which would affect drug companies’ patent rights. [...]

Senate Judiciary to Consider Drug Pricing Bills

SENATE JUDICIARY TO CONSIDER DRUG PRICING BILLS Today at 10:00a.m. ET the Senate Judiciary Committee will hold a meeting to consider several drug pricing bills including S. 440, the Preserving Acce[...]

Dismissal of Compliant Improper Where Factual Allegations Sufficient to Establish Plausible Inventiveness of Claims

* * DISMISSAL OF COMPLAINT IMPROPER WHERE FACTUAL ALLEGATIONS SUFFICIENT TO ESTABLISH PLAUSIBLE INVENTIVENESS OF CLAIMS Cellspin Soft, Inc. v. Fitbit, Inc., 18-1817 -- Yesterday in an[...]

U.S. Supreme Court Holds Immoral or Scandalous Provision of Trademark Act Invalid Under First Amendment

* * * * U.S. SUPREME COURT HOLDS IMMORAL OR SCANDALOUS PROVISION OF TRADEMARK ACT INVALID UNDER FIRST AMENDMENT Iancu v. Brunetti, 18-302 -- Yesterday in an opinion by Justice KAGAN, the U.S. Supre[...]

Addition of Real-Party-In-Interest Did Not Require Altering IPR Petition’s Filing Date

* * ADDITION OF REAL-PARTY-IN-INTEREST DID NOT REQUIRE ALTERING IPR PETITION’S FILING DATE Mayne Pharma Int’l Pty. v. Merck Sharp & Dohme Corp., 18-1593 -- On June 21 in an opinio[...]